Raynaud-like phenomenon in two patients on nilotinib
Sezary syndrome presenting with tumourous involvement of the breast detected by 18F-fluorodeoxyglucose positron-emission tomography/computed tomography
Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term
Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products
Guideline for the diagnosis and management of myelofibrosis
Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study
Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis
In non-follicular lymphoproliferative disorders, IGH / BCL2 -fusion is not restricted to chronic lymphocytic leukaemia
Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocol
A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma
The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML
Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state
Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4–5 years
Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia
Blood transfusion in a developing society. Who is the best blood donor?
Blood transfusion in a developing society. Who is the best blood donor? – Response to Charles et al
Normalized CCND1 expression has prognostic value in mantle cell lymphoma
Mutation in the THPO gene is not associated with aplastic anaemia in Japanese children
Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3
Corrigendum
UK NEQAS for Blood Coagulation Annual Scientific Meeting 4–5 September 2012, Sheffield Hallam University, Sheffield, UK